Market Research Logo

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, as well as food supplements and other health care products. The company offers its products to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets. Navamedic offers its pharmaceutical products under mouth and throat health, dermatology, urology, gynecology, cardiology and other categories; and medical devices under urine measurement and psychiatry categories. The company also distributes products supplied by a several pharmaceutical manufacturers. Navamedic is headquartered in Lysaker, Oslo, Norway.

Navamedic ASA Key Recent Developments

Jul 28,2017: Navamedic ASA: Second quarter results 2017
Jul 28,2017: Navamedic: Second quarter results 2017
May 10,2017: Navamedic: Q1 2017 Results
Feb 15,2017: Navamedic: Q4 2016 results
Nov 11,2016: Navamedic: Q3 2016 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Navamedic ASA - Key Facts 5
Navamedic ASA - Key Employees 6
Navamedic ASA - Key Employee Biographies 7
Navamedic ASA - Key Operational Employees 8
Navamedic ASA - Major Products and Services 9
Navamedic ASA - History 10
Navamedic ASA - Company Statement 14
Navamedic ASA - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 16
Navamedic ASA - Business Description 16
Navamedic ASA - Corporate Strategy 17
Navamedic ASA - SWOT Analysis 18
SWOT Analysis - Overview 18
Navamedic ASA - Strengths 18
Navamedic ASA - Weaknesses 19
Navamedic ASA - Opportunities 20
Navamedic ASA - Threats 21
Navamedic ASA - Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31
Navamedic ASA, Recent Deals Summary 32
Section 5 – Company’s Recent Developments 33
Jul 28, 2017: Navamedic ASA: Second quarter results 2017 33
Jul 28, 2017: Navamedic: Second quarter results 2017 34
May 10, 2017: Navamedic: Q1 2017 Results 35
Feb 15, 2017: Navamedic: Q4 2016 results 36
Nov 11, 2016: Navamedic: Q3 2016 Results 37
Aug 23, 2016: Navamedic appoints new CFO 38
Aug 18, 2016: Navamedic: Q2 2016 RESULTS 39
May 11, 2016: Navamedic: Q1 2016 Results 40
Feb 18, 2016: Navamedic announces Strong Sales - Product Launch Affected Profitability 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
Navamedic ASA, Key Facts 5
Navamedic ASA, Key Employees 6
Navamedic ASA, Key Employee Biographies 7
Navamedic ASA, Key Operational Employees 8
Navamedic ASA, Major Products and Services 9
Navamedic ASA, History 10
Navamedic ASA, Subsidiaries 15
Navamedic ASA, Key Competitors 22
Navamedic ASA, Ratios based on current share price 23
Navamedic ASA, Annual Ratios 24
Navamedic ASA, Annual Ratios (Cont...1) 25
Navamedic ASA, Annual Ratios (Cont...2) 26
Navamedic ASA, Interim Ratios 28
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31
Navamedic ASA, Recent Deals Summary 32
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45
List of Figures
Navamedic ASA, Performance Chart (2012 - 2016) 27
Navamedic ASA, Ratio Charts 29
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 31

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report